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Abstract: Eating behaviour is characterised by a solid balance between homeostatic and hedonic
regulatory mechanisms at the central level and highly influenced by peripheral signals. Among these
signals, those generated by the gut microbiota have achieved relevance in recent years. Despite this
complex regulation, under certain circumstances eating behaviour can be deregulated becoming
addictive. Although there is still an ongoing debate about the food addiction concept, studies agree
that patients with eating addictive behaviour present similar symptoms to those experienced by drug
addicts, by affecting central areas involved in the control of motivated behaviour. In this context, this
review tries to summarise the main data regarding the role of the gut microbiome in eating behaviour
and how a gut dysbiosis can be responsible for a maladaptive behaviour such as “food addiction”.
Keywords: food addiction; eating behaviour; reward; obesity; gut-microbiome; gut-dysbiosis
“All disease begins in the gut.”
Hippocrates
1. Introduction
Despite wide daily variation in food intake and energy expenditure, in most subjects
body weight remains constant over long periods of time, due to a continuous regulation of
both processes. This regulation is tightly controlled through effects on the energy store,
integrated by the central nervous system (CNS) and modulated by endocrine and nervous
signals from peripheral organs [1]. However, this homeostatic pathway can be neutralized
by a more flexible non-homeostatic pathway. In fact, external cues, cognitive and emotional
factors can override the homeostatic process and finally the motivational and reward
pathways become crucial in the regulation of eating behaviour, hence food intake process
goes beyond metabolic needs [2–4]. If this deregulated situation is maintained over time,
it can lead to complicated and addictive behaviors, such as the behavioral addiction to
eating [5,6]. In this context, the gut, with its own nervous system, the enteric nervous
system (ENS), is considered as a second brain due to its direct communication network
with the CNS and plays a key role by regulating both homeostatic and non-homeostatic
responses. This network integrates gut signals and links them, mainly through the vagus
nerve, to cognitive and reward centres of the brain, therefore modulating behavioral
responses [7]. Furthermore, over recent years, an interesting new actor has emerged in this
equation, hence we can talk now about the “gut–microbiota–brain (GMB) axis” [8,9]. The
gut microbiota (GM) is composed of a complex and dynamic population of microorganisms
that offer many benefits through their close interaction with the host. These symbiotic
microorganisms are not only essential for the fundamental physiological functions and to
maintain gastrointestinal (GI) homeostasis, but a growing body of evidence supports that
this “superorganism” may also interact with the host neuroendocrine system and modify
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brain development and responses, resulting in modifications of the host behaviour [10–12].
Similarly, gut microbiota could be a stressor target in maladaptive behaviors. In fact,
environmental, physical and psychological stress present in daily life has been linked
to gut dysbiosis. Adding support to this contention, both in animal and human models
it has been demonstrated that the manipulation of GM alters levels of stress hormones
and the ingestion of specific probiotics could rectify some of the abnormalities observed.
Hence, a healthy bidirectional communication system between GM and the CNS is an
essential element to prevent psychological disorders [13]. Noteworthy, evidence emerging
from both human and animal studies proposes that GM has essentially contributed to
current cognitive development and human social behaviour [14,15]. Because of the vast
body of literature respecting this topic, the main focus of this mini-narrative review will
be to provide a concise overview of the current research regarding the interrelationship
between gut microbiome dysbiosis and dysfunctional eating behaviour, such as food eating
addiction. In order to contextualize their relevance, these aspects will be preceded by a
brief summary of the physiological role of the non-homeostatic pathways and the GM
in the regulation of food intake and eating behaviour. Finally, future directions will be
discussed. Decoding in depth the role of GM in food addiction could provide promising
opportunities for future therapeutic options.
2. Non-Homeostatic Contribution to Regulation of Food Intake
As has been mentioned above, food intake behaviour is a highly regulated process
by many redundant mechanisms. This regulation is the result of the integration of two
neuronal circuits that overlap both anatomically and functionally: the homeostatic pathway,
which controls the energy balance by triggering food intake in response to a depletion of
energy stores, and the more flexible non-homeostatic one, hedonic or reward-based, which
is driven by pleasurable emotions and previously learned behaviors. Current data based on
opto- and chemo-genetic studies conducted in animal models, support that these two key
systems are part of a more complex motivational system and both cannot be functionally
dissociable from one another [5,16]. In this context, the lateral hypothalamic area (LHA) is
a crucial area integrating homeostatic and reward-related central and peripheral signals
and coordinating adaptative behavioral responses to the nutritional background. Hence,
the LHA serves as a reward–motivation–cognition hub. Interestingly, in addition to being
implicated in feeding behaviors, LHA regulates sleep/wake states and arousal, so finally
the decision to eat can be also modulated by circadian time [17–20]. However, due to the
impact of the present food environment, the hedonic pathway is continuously tested and
overwhelmed by countless signals contributing to a deregulated circuit and finally to the
development of eating disorders.
Historically, reward-based regulation is comprised of three different aspects: “liking”,
“wanting” and “learning”, that despite being highly connected can be disassociated anatom-
ically and manipulated in animal models to obtain behaviors that are either exclusively
pleasant or motivational in response to a food stimulus. Hence, while “liking” is closer to
sensory processes, “wanting” is closer to decision making and goal-seeking, by reflecting
the cue-driven tendency to choose one behaviour rather than another to optimize rewards.
One decisive mechanism for disordered eating is the progression from normal “liking”
and “wanting” to addictive behaviour. On the other hand, the “learning” process includes
associations with anticipation of rewards [21,22]. In fact, data obtained on animal models
suggest that the repercussions of food intake can be predicted and accommodated in re-
sponse to external food cues based on previous experiences [23,24]. In this regard, efferent
information through the visual, olfactory, auditory and oral taste systems is integrated
with large areas of the brain, constituting our food memories that will modulate future
eating behaviors [2]. Hence, in the course of time, animals not only undergo rewards, but
also anticipate them [25]. This cue-induced anticipation can lead to devaluation of recom-
pense value; however, a malfunctioning of such behaviour may propitiate an unsuitable
responding to food cues and dysregulation of food intake [26]. In this sense, recent data,
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obtained from animal models, have demonstrated that chronic consumption of refined,
high-fat or high-sugar diets can cause persistent aberrations in behavioral control resulting
in insensitivity to food devaluation and increasing impulsive decision and cravings [27,28].
In agreement, it has been proposed that overeating observed in obese humans can be due
to a lower adaptation of eating behaviour with respect to changes in motivational value. In
consequence, obese humans exhibit maladaptive behaviors such as eating in the absence of
hunger, or present late meal cessation [29].
On the other hand, many rewards act as instrumental reinforcers determined by the
balance between goal-directed (or “conscious”) and habitual (or “automatic”) processes [30].
Usually, high-value reinforcements, such as palatable food, can cause a pathological im-
balance of these behaviors. In fact, these positive stimuli are known to bias behaviour
toward the “habit system” and to accelerate habit formation [31,32]. Thence, food intake
will be initiated without previous wanting and this action will not be finished even if the
motivational value has already decreased [33]. Although, initially, habits can be helpful
and adaptative in daily life, these may result in becoming rigid and inflexible. There-
fore, the lack of the ability to shift back to cognitive behaviour will cause some habits
to become obsessive and compulsive under different circumstances, such as stress and
anxiety [33–35]. Taking all these data together, it is easier to understand why a positive
correlation between anxiety and food addiction is normally observed. Indeed, the emo-
tion dysregulation theory, which comprises the inability to flexibly respond to and direct
emotions, has been proposed as a predictor of food addiction [36]. Moreover, uncontrolled
emotional eating can be a coping mechanism to regulate distress, despite the negative
consequences [37,38]. Finally, to highlight similarities with other natural rewards and with
drug abuse, a maladaptive reinforcer devaluation process can evoke an aversive state when
having to wait for access to the liked/wanted reward. Hence, while in the first instance
a binge eating behaviour is positively reinforced, the palatable food ultimately acquires
negative reinforcing properties [25].
The neuro-regulation of these processes is based on a complex network, which, ac-
cording to a great deal of evidence, shares the same brain pathways as other addictive
substances and behaviors [39,40]. Non-homeostatic factors are mainly processed in corticol-
imbic structures such as the prefrontal cortex (PFC), predominantly within the orbitofrontal
cortex (OFC) projections, the amygdala, nucleus accumbens (NAc) and ventral tegmental
area (VTA), where opioids and dopamine (DA), together with other neurotransmitters, are
released promoting the sensation of pleasure and incentive salience, respectively. Hence,
the dopamine striatal system is mainly (although not exclusively) involved in “wanting”,
and the opioid and cannabinoid systems are mainly (although not exclusively) involved
in food “liking” [41]. Although the mesolimbic dopamine pathway from the VTA to the
striatum has been perhaps the most strongly linked to reward, over recent years, the PFC
areas have gained functional relevance due to their role in focusing attention, controlling
motivation and assigning reward value. Indeed, PFC acts as a top-down mechanism to
suppress the bottom-up drives, such as impulsivity coming from the ventral striatum and
compulsivity from the dorsal striatum [42]. To be noted, within prefrontal circuitries, two
opposing systems have been described; one which motivates craving and involves habits,
a “GO system”, specifically the prelimbic cortex (PL), and one which instead inhibits these
behaviors by suppressing emotional responses to stimuli, a “STOP system”, located in the
infralimbic cortex (IL) [43,44]. An imbalance of both systems with increased responsiveness
to food cues could explain the abnormal activation of PFC regions observed in drug/food
addicted humans [45].
On the other hand, metabolic signals from the periphery can also modulate all levels of
food-related cognitive and reward processing. In this context, adipocyte-derived hormones,
such as leptin, exert a wide influence across many reward-implicated brain regions by
modulating midbrain dopamine and opioidergic pathways and finally suppressing the
incentive value of food [46–48]. Likewise, GI hormones, acting either directly from the
bloodstream or via the vagus nerve, have a great impact on eating behaviour [17]. In this
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sense, ghrelin, the only known peripherally-derived orexigenic peptide hormone secreted
from the stomach, also reinforces food reward, in part through amplification of dopamin-
ergic signaling mechanisms [49]. Contrarily, many anorexigenic enteroendocrine signals,
such as peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), suppress reward function
and can increase anxiety-like behaviour [50]. Finally, the influence of gonadal hormones,
such as estrogens, should be remarked in energy homeostasis, both in homeostatic and
non-homeostatic components. Knowing the function of estrogens in eating behaviour can
help us to understand why women are more vulnerable to eating disorder (ED) symptoms.
Indeed, ED prevalence is the most solid sex difference in all psychiatric pathologies, with
women being up to ten times as likely as men to suffer from an ED [51,52].
As previously recorded, reviewing in depth the neuro-regulation of the non-homeostatic
component of food intake and eating behaviour is complex and beyond the aim of this paper,
but detailed manuscripts on this topic can be found elsewhere [5,16,17,52–54] (Figure 1).
Figure 1. Non-homeostatic aspects implicated in the regulation of eating behaviour. The reward-based regulation is
comprised of three different aspects: “liking”, “wanting” and “learning” that can be disassociated anatomically in different
brain areas. Amy, amygdala; Hippo, hippocampus; Hyp, hypothalamus; Nac, nucleus accumbens; PFC, prefrontal cortex;
SN, substantia nigra; VTA, ventral tegmental area. All these areas can be modulated by different peripheral signals.
3. Gut Microbiota: A Key Player in the Regulation of Eating Behaviour
Supported by abundant research, it is well-known that a sophisticated bidirectional
communication network exists between the gut and the CNS. This gut–brain axis, with
high influence on behaviour and other basic CNS functions, is composed of the cited
CNS, the ENS, the sympathetic and parasympathetic branches of the autonomic nervous
system (ANS) and the hypothalamic–pituitary–adrenal (HPA) axis [9,55,56] (Figure 2). In
addition, over recent decades, a new decisive player has emerged in this equation [57].
Living gut microorganisms and their bioactive metabolites, including short-chain fatty
acids (SCFAs) and conjugated fatty acids among others, and their neuroactive metabolites,
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such as serotonin (5-hydroxytryptamine; 5-HT) and γ-aminobutyric acid (GABA), are
released in the bloodstream and can modulate the CNS directly or indirectly by affecting
the ANS [58–60]. Hence, changes in enteric neuron activity will be perceived by the
vagus nerve to modulate, among other physiological aspects, appetite, satiety, stress, and
mood. This fact is in accordance with data obtained from rodent models. In this sense,
ingestion of probiotics, such as Bifidobacterium longum NCC3001, induces activation of the
vagal sensory neurons that innervate the GI enhancing exploratory behaviour in healthy
mice [61]. However, mice that have undergone vagotomy did not show the same positive
changes in emotional behaviour after probiotics ingestion, as was also observed in intact
animals after Lactobacillus rhamnosus JB-1 treatment [62]. In agreement, promising results
from clinical trials on humans show that probiotic ingestion is associated with changes
in the activity of multiple brain areas involved in emotional processing, including the
amygdala and fronto-limbic regions [63]. In addition, to interact with the vagus nerve,
some bacterial strains can also influence gut hormone secretion, including PYY, GLP-1,
leptin, and ghrelin, and thus affect appetite and satiety via hypothalamic neuroendocrine
pathways [64–66].
Likewise, since the GI tract comprises the large junction between the microorganisms
and the immune system, GM is able to modulate this, as well as cytokine production [67].
These cytokines will also be released and act on the CNS, provoking changes in host
behaviour, especially related to social conduct. In fact, inflammatory activity can alter
cognition and motivation, having important consequences on eating behaviour [68]. In this
context, it has been described that inflammatory mediators can act on cortico-amygdala
threat and cortico-basal ganglia reward circuitries, predisposing individuals to addictive
habits and increasing consumption of highly palatable diets [69]. In addition, GM also
regulates microglial maturation and function [70,71]. Interestingly, microglia, the major
player in brain inflammation, is essential for the development and preservation of addictive
behaviors by influencing neuronal and synaptic functions in diverse ways [72]. Indeed,
Gutiérrez-Marcos et al. demonstrated that microglia activation and neuroinflammatory
processes induced overeating behaviour in mice. The access to highly palatable food led to
overconsumption and caused functional alterations in the reward system, especially in the
NAc [73]. Besides, in inflammatory states, overactivation and dysregulation of microglia
can have important consequences on blood–brain barrier (BBB) integrity [74].
Finally, we highlight that GM can itself be considered as a “virtual endocrine or-
gan” [75]. GM and the factors that it produces interact with the host endocrine system,
disturbing both brain function and eating behaviour [76]. Moreover, GM can affect the
postnatal development of the stress response [77] and exacerbate this response via the HPA-
axis [78] as observed in pre-clinical models. It has been previously mentioned that stress
is a crucial factor in eating behaviour by regulating food preference and it has also been
described as the common factor behind some eating-associated disorders [79,80]. Likewise,
food cues and a stressful environment can promote food craving and intake by increasing
total ghrelin and cortisol levels [81]. Hence, changes in stress-related neurohormones, such
as norepinephrine and epinephrine, could be one of the mechanisms through which GM
modulates food intake.
On the other hand, the brain has a prominent role in the modulation of gut activi-
ties. Indeed, it can affect microbiota composition and function by alteration of intestinal
permeability and by stimulating the immune response [82]. Hence, interruption of these
bidirectional interactions and changes in the microbial environment can be involved in
the pathogenic pathways responsible for the development of CNS disorders, as has been
demonstrated by different studies. In fact, neuropsychiatric comorbidity is a common find-
ing in patients with a functional GI disorder and/or gut dysbiosis [55,83–85]. Consequently,
microbiome-based strategies, including prebiotics, probiotics and fecal transplants, as well
as dietary changes, have been proposed as new therapeutic treatments to improve mental
health [86–88]. Indeed, some probiotics capable of producing neuroactive substances have
been described as psycho-biotics due to their potential to act as psychotropic agents [89].
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Figure 2. Bidirectional communication network between the Gut and the Central Nervous System (CNS). Gut microbiota
and microbial metabolites are able to regulate the host energy metabolism and host eating behaviour by acting on the CNS
through different pathways. On the other hand, CNS modulates microbiota composition and function.
The GM is constituted by a huge population of microorganisms, consisting predomi-
nantly of different phyla of bacteria, and a small number of viruses, protozoa and fungi.
Although the microbiota composition in the GI is reflective of life events such as illness, an-
tibiotic treatment and mainly dietary habits, being modulated over time, a “healthy gut mi-
crobiota” is characterised by the presence of Firmicutes and Bacteroidetes, as well as Actinobac-
teria, Proteobacteria, Fusobacteria and Verrumicrobia phyla in relatively low amounts [11,90].
As already mentioned, gut microorganisms provide a wide variety of beneficial functions
to the host as a result of their own metabolism.
Under anaerobic conditions, undigested carbohydrates are fermented mostly into
SCFAs, such as acetate, propionate and butyrate. These molecules have multiple effects,
principally on host metabolism [91]. Noteworthily, both preclinical studies [92–94] and
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clinical studies [95] have demonstrated that dietary supplementation of SCFAs protect from
metabolic disorders, such as obesity [96]. In this context, an important work conducted
by De Vadder et al. showed that these microbiota metabolites are able to induce intesti-
nal gluconeogenesis via different mechanisms and finally to promote metabolic benefits,
such as reduced body weight and improved insulin sensitivity, etc., through the activa-
tion of specific brain targets, some implicated in appetite control [97]. Accordingly, gut
dysbiosis, which causes disruption of SCFA metabolism, can promote hyperinsulinemia
and potentially increase hedonic intake [98]. In agreement with these data, other studies
also highlight the important role of SCFA in eating regulation [99]. In fact, this has been
demonstrated in animal models exposed to an HFD and highly fermentable carbohydrate
(FC), as the acetate derived from the colon was able to induce an anorectic signal in the
hypothalamus [100]. In contrast, Perry et al. described how in HFD-fed rats acetate led to
increased ghrelin levels and glucose-stimulated insulin secretion that ultimately promoted
hyperphagia [101]. Hence, although there is clear evidence regarding the interrelation of
acetate and central effects on appetite regulation, other aspects and apparent discrepancies
should still be covered in-depth [102]. On the other hand, in animal models, both butyrate
and propionate have also been proposed as intermediate signals regulating food intake that
exert their anorectic effect by modulating gut hormone release [93,103]. Analogous results
were observed in human models. Indeed, propionate significantly stimulated the release
of anorexigenic hormones PYY and GLP1 from human colonic cells. In agreement, Cham-
bers et al. observed that, after acute delivery of propionate, specifically to the colon, healthy
subjects showed an increase in plasma levels and PYY and GLP-1 levels, and consequently
inhibition of energy intake [104]. Therefore, Torres-Fuentes et al. showed how SCFAs and
other microbiota metabolites can attenuate ghrelin receptor signaling [65]. In addition, pro-
pionate is able to attenuate the reward effects on feeding behaviors through a reduction in
anticipatory response to high-energy foods via the striatal pathway, decreasing caudate and
NAc activity [105]. Similar results were found by Li et al. in a well-conducted work. These
authors demonstrated how butyrate administration reduced appetite, activated thermoge-
nesis and improved lipid and glucose metabolism via vagal nerve signaling in mice [106].
Despite these promising results, it remains to be determined if all these metabolic benefits
can be extrapolated to humans [107]. Additionally, bidirectional interactions between
bile acid synthesis and gut microbiota have also been implicated in the regulation of host
metabolism [108]. Gut microbiota-derived secondary bile acids act through the nuclear
farnesoid X receptor (FXR) and the Takeda G protein-coupled membrane receptor 5 (TGR5)
to regulate different peripheral metabolic pathways [109]. Moreover, acting directly in
hypothalamic TGR5 [110] and through diverse indirect pathways can also signal to the
CNS to regulate food intake [111,112]. In turn, bile acid signaling can influence microbial
composition [113]. Interestingly, both gut microbes and their different metabolites can act
as modulators of BBB integrity, hence altering the permeability to peripheral hormones
and other factors which can regulate brain activity [74].
The intestinal microbiota is one of the main sources of neurotransmitters. Accumulat-
ing evidence in pre-clinical studies highlights that, by manipulating the microbial composi-
tion of the GI, neurotransmitter levels can be altered and potentially affect both the enteric
and central nervous systems [114]. Over 90% of 5-HT, which modulates melanocortin
neurons to mediate its anorexigenic effect [115], is produced in the GI tract by enterochro-
maffin cells (ECs). Remarkably, it has been observed that indigenous microbiota is able
to modulate the peripheral levels of 5-HT by increasing its biosynthesis in a postnatally
inducible and reversible manner due to an upregulation of tryptophan hydroxylase 1, the
rate-limiting enzyme in the biosynthesis of serotonin [116]. These results, observed by Yano
et al. in samples from the colon of mice and from a healthy human colon, also highlight
that human- and mouse-derived gut microbiota can promote colonic 5-HT production
through stimulatory activities of SCFAs on EC cells. Likewise, secondary bile acids can
regulate the 5-HT synthesis and its release from EC cells [116,117]. Besides SCFAs, mi-
crobial tryptophan catabolites, such as tryptamine, are able to stimulate 5-HT production
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and to affect cognitive functions and host activities [118,119]. Likewise, other tryptophan
catabolites, kynurenine, quinolinate, indole, and indole derivatives, among others, are able
to signal specifically to the brain and finally to influence behaviour [120]. Moreover, the
deconjugation process of glucuronide-conjugated 5-HT by bacterial enzymes could be one
of the mechanisms via which commensal microbiota modulates 5-HT host levels [121].
GABA, the main inhibitory neurotransmitter in the CNS, can also be affected by the
GM [62,122,123]. In fact, manipulating microbiota composition by fecal microbiota trans-
plantation may alter GABA levels [124] and have a great impact on hypothalamic feeding
regulation [125]. GABAergic neurotransmission in hypothalamic neurocircuits stimulates
feeding and its synaptic release by agouti-related protein-expressing neurons in the arcuate
nucleus (ARC), required for normal regulation of energy balance [126]. On the other hand,
GABA participates in the cognitive choice of selecting the type, quantity and quality of food.
In this sense, stimulation of GABA receptors in the ventral pallidum (VP) induces behav-
ioral effects similar to those observed after accumbens dopamine depletion [127]. Hence,
besides VTA-Nac dopaminergic pathway, VP plays a crucial role in the processing and
achievement of effort-related choice and motivated behaviors [128,129]. Additionally, as
has been previously described in this manuscript, PFC plays an important role in cognitive
functions related to eating and in the top-down control of this behaviour. Noteworthy, the
regulation of GABAergic neurotransmission is critical for a proper inhibition of PFC activity
under maladaptive behaviors, since PFC hyperactivation can cause impairment of working
memory and other cognitive functions [130]. In this context, it has been confirmed in
animal models that the exposure to hypercaloric diets decreased GABA levels in PFC [131],
partly due to changes in microbiota [132]. These GABA level disturbances could impair
the inhibitory processes and finally, lead to overeating regardless of satiety sensation.
Besides these neurotransmitters, the microbiota has been shown to synthesize and
induce the activity of other neurochemical compounds, such as DA and histamine, which
are also able to modulate the host mood and behaviour [114,133], to a point some authors
are already describing as the “psychobiome” [134,135].
4. Food Addiction: A New Mental Disorder?
“Addiction is defined as a chronic, relapsing brain disease that is characterised by compul-
sive drug seeking and use, regardless of unhealthy consequences and long-lasting changes in the
brain” [136]. In fact, addiction reduces the control over decision-making skills by inducing
changes in PFC neurons and in basal ganglia activities, among other brain structures [137].
This induced neuroplasticity process perturbates the brain reward homeostasis and leads
to more habitual and more compulsive drug use/behaviour [138,139].
Almost anything in the human environment can be rewarding, giving it the capacity
to become addictive. According to this, food and related eating behaviors, like any other
stimulus, can cause an addiction. However, there is still an ongoing debate in the scientific
community regarding the “food addiction concept” and this paradigm is recurrently
revisited, as usually happens with other diseases and mental disorders [5,6,140–148].
Indeed, the concept is not new, and has been in constant evolution through the years [145],
with increased interest in recent decades. In this context, major controversy exists because
food addiction can be considered as a substance-related disorder (food addiction), or a
non-substance-related disorder (eating addiction). Hence, while some authors report that
people can be addicted to sugar, salt, additives, and high-fat content [149–153], others
argue that a behavioral addictive disorder better describes eating problems [6,154]. Finally,
a third position has been taken by other researchers, who consider that food addiction is an
unnecessary term that could increase the medicalization of common behaviors [155,156].
In agreement, some authors call attention to the fact that using food addiction as a term
might increase stigmatizing attitudes, accordingly having an impact on the treatment of
these disorders [157].
Addiction is comprised of three steps: preoccupation/anticipation (craving), binge/int-
oxication, and withdrawal/negative effect. All these aspects have been confirmed, at least
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in animal models [5]. However, some authors consider that these steps are not convincingly
observed in the context of human food addiction [158]; consequently, they suggest current
models of addiction should be re-evaluated. To be noted, since food intake is essential for
survival, and eating behaviour is an important social practice [159], these aspects should
be contemplated when approaching eating disorders.
Many addiction researchers and clinicians, describe “addiction” as a brain disease [160,161],
which can be partly explained by the DA deficiency hypothesis [162]. According to this
hypothesis, some subjects will be immersed in abnormal craving behaviors, such as over-
consumption of highly rewarding food, to compensate for the DA deficiency [163]. In
fact, compulsive-like feeding behaviour in obese rats was linked to the downregulation of
striatal dopamine D2 receptors (D2Rs). Likewise, after silencing striatal D2Rs in rats, these
animals showed compulsion-like food seeking [164]. Besides DA deficiency, these subjects
also present a dysregulation of other neurotransmitters. On the other hand, a new learning
model has been proposed recently to explain how addictive behaviors could take place.
This model suggests that addictive behaviour is learned and is not the result of pathologic
brain signaling [165]. Since our brain is plastic, we can modify our behaviors throughout
our lives by learning new habits to adapt to changes in our environment. In fact, as already
pointed out by Dr Woods thirty years ago, food itself is necessary but the act of eating is
disruptive, accordingly humans have to learn new responses to tolerate it [166]. Regardless
of the vision of addiction as a brain disease or as a learning process, both highlight that
addiction is a maladaptive behaviour with adverse consequences. Probably, addictive
eating behaviors can be explained by a sum of both models, due to a close interaction
between brain changes and social conditions. Noteworthy, if our brain can change in a
negative manner as observed in addiction, could our brain switch in a healthier way by
adopting new habits?
5. Interrelationship between Gut Microbiota and Food Addiction
A great number of studies have implicated the GM as a key modulator of brain and
behaviour, and have shown how bidirectional communication through the GMB axis is
essential for the regulation of host metabolism and energy homeostasis [9,167]. How-
ever, fewer studies have been conducted to answer how the microbiota might influence
addiction-related behaviors, such as “food/eating addiction”. Even though the research to
date is not complete, increasing evidence shows how microbiota dysbiosis is implicated in
the development of these maladaptive habits [8,10,58,168–172] (Figure 3). Considering this,
all factors affecting the “healthy” composition of the GM, including host genetics [173,174],
diet [175,176], age [177,178], mode of birth [179,180], and antibiotics intake [181,182], among
others, can shape GM and ultimately trigger an abnormal eating behaviour. In fact, recently,
Dong et al. have reported that females with obesity and food addiction present a different
GM when compared to females without these conditions [183]. Noteworthy, some of these
changes can be the result of prenatal factors, similar to the fetal programming described
in the context of other mechanisms regulating food intake [184,185]. Different studies
conducted in animal models have highlighted that changes in maternal microbiota during
pregnancy influence neonatal gut microbiome and have permanent effects on offspring
behaviour. Probably, the role of maternal diet during the gestation period has been the
most commonly studied factor. Both human and non-human studies evidence that there is
a close association between maternal diet, maternal microbiome and infant microbiome.
Hence, nutrition during pregnancy modulates maternal microbiota, and this could lead to a
negative impact on offspring brain development due to infant dysbiosis [186,187]. Accord-
ingly, all gestational complications affecting maternal microbiomes can potentially cause
neurodevelopmental disorders and exert long-lasting effects on offspring behaviour [188].
Interestingly, Jasarevic et al. demonstrate that changes in the composition of maternal vagi-
nal microbiota due to a stressful situation can influence offspring gut and hypothalamus
increasing the risk of neuro-disorders [189].
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Figure 3. Gut-brain axis and dysbiosis. Possible mechanisms implicated in the development of
addictive like-behaviors, such as “food addiction”, as result of a brain disrupted signaling.
Besides these pre- and neonatal influences, the microbiota is highly susceptible to
change in early life. In this context, breastfeeding or formula feeding might have a role in
future behaviour by modulating GM infant composition differently [190]. Breastfeeding
has been positively associated with early brain development and cognitive function as
observed by Liu et al. In this study, conducted in infant rhesus macaques, authors describe
significant brain structural differences between breastfed, which promoted maturation of
cortical areas, and formula-fed animals [191]. Interestingly, studies conducted on children
have also shown that breastfed subjects have healthier dietary patterns in life [192]. Con-
sidering all these data, we could conclude that any perturbation of host-microbiota during
a critical window period has persisting consequences in host-metabolism, as observed in
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mice [193]. On the other hand, during this period, the microbiome has an important role in
programming the HPA axis for stress response, as already mentioned [77]. In agreement,
chronic early-life stress, such as maternal separation, in mice leads to intestinal dysbiosis,
which determines abnormal behaviors [194]. These aberrant effects could be mediated
by disruption in the myelination and brain development processes, since as observed
in pre-clinical models early-life microbiome is implicated in the myelination of PFC and
synapse strial function, both areas crucial for proper eating behaviour [195,196]. However,
since most research has been conducted in animal models, more data from human studies
are needed to decode if these perturbations might increase the risk of developing eating
disorders in adulthood.
In addition to early-life influences, dysbiosis can result from exposure to other envi-
ronmental factors throughout life, including diet, toxins, drugs, and pathogens, as well as
social stress. Depending on the predominant macronutrients in the diet, different species
of microorganism will be stimulated in the GM. In this sense, the Western diet, rich in fat
and simple carbohydrates with low levels of fiber, results in less diversity of the intestinal
microbiota. Moreover, Sonnenburg et al. showed in humanized mice that the loss of diver-
sity in the composition of GM after western diet (WD) intake was magnified over several
successive generations [197]. This shift to an “unhealthy” microbiota composition induced
by the WD influences brain function and induces addictive-like eating behaviors [198].
Studies conducted both in humans and animal models confirm that consumption of highly
palatable food and ultra-processed food typical of WD is closely related to the development
of these maladaptive habits [199–202]. Based on these data, the vicious cycle hypothesis has
been proposed. Accordingly, the diet provides the substrate for the GM, which modulates
appetite by signaling the brain, and finally CNS mediates the preference for specific foods,
and the cycle starts once more [198].
One of the potential mechanisms proposed to explain brain alterations has been the “leaky
gut” [203]. An imbalanced GM induces changes in gut permeability, hence increasing the
translocation of microbial metabolites, known as endotoxemia, from the lumen of the GI tract
to the adjacent tissues and finally to the systemic circulation. These metabolites can signal the
brain to modulate host behaviour, which can explain why many CNS disorders have been
linked to a compromised gut barrier [204]. Noteworthy, a damaged intestinal barrier results
from some of the factors already commented, such as WD and stress, among others.
Importantly, many microbiota-associated changes occur in a sex/gender-dependent
manner and these differences can influence the brain and behaviour [205–207]. In this
context, women report higher food addiction behaviors, cravings and reward sensitivity
than men [208,209]. Accordingly, recently, sex addiction-phenotype and related behaviors
have been associated with the microbiome in a rodent model [210]. All these data highlight
that that the close interaction between microbiota and sex/gender should be considered in
future studies.
6. Conclusions
How the gut microbiota signals the brain to regulate eating behaviour has been
the subject of significant research over the past decade and there is no doubt that the
gut microbiome plays a crucial role in host metabolism and eating behaviour. However,
although the evidence suggests that targeting the microbiota could serve as a promising
therapeutic option for some mental disorders, such as addiction-like behaviors, to date
the majority of data on the microbiota–gut–brain axis has been obtained from studies
using animal model systems. Animal studies are basic in understanding some molecular
mechanisms, but these potential clinical implications should be assessed in-depth in clinical
models. Despite these limitations, one of the most hopeful treatments for modifying the
GM to improve eating disorders would be the use of probiotics and prebiotics, not only
to treat but also to prevent the unhealthy microbiome disbalance. Our microbial system
is complex, but it has been already mentioned throughout this manuscript that it directly
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impacts on our cognitive function and mood. Therefore, every positive impact on our
microbiota due to probiotics intake should be considered in the context of eating disorders.
On the other hand, irrespective of the “food addiction” concept, researchers from
different fields including neuroscience, neuroendocrinology, psychology, and many others
should work together and go forward to fill existing knowledge gaps and to provide a
valid framework for the prevention and treatment of addictive eating behaviors. In this
context and considering the state of the art, both pharmacological treatments and cognitive
behavioral interventions should be considered. Finally, although evidence suggests that
obesity, binge eating disorder (BED) and addictive eating behaviour share the same reward
pathways, and furthermore some of their symptoms can overlap, they are considered as in-
dependent pathologies. Hence, even if obesity, eating disorders, addictive eating behaviour
and other addictions could be intimately connected, they should be approached differently.
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